Select Page

Updated Operational Guidance for Implementing CDC’s Recommendations on Testing for Hepatitis C Virus Infection
“New guidance for completion of HCV testing supports operational strategies that collect samples at a single visit, and automatic HCV RNA testing on all HCV antibody reactive samples. Use of strategies that require multiple visits to collect samples should be discontinued.”

Virginia Health Clinic Provides Blueprint for Treating Local HCV Patients with Substance History
“A community-based hepatitis C virus (HCV) treatment program was able to successfully cure a small cohort of patients with a history of drug use who received care from a nurse practitioner at a Federally Qualified Health Clinic (FQHC) over 12 weeks.”

Lowering HCC incidence threshold in guidelines cost-effective, may improve early detection
“Research demonstrated that hepatocellular carcinoma surveillance is cost-effective at a lower incidence threshold of 0.7% in virologically cured patients with hepatitis C virus, underscoring the need to update clinical guidelines.”

10 Reasons To Get Tested For Hepatitis C
“Though the Centers for Disease Control and Prevention (CDC) recommends that everyone does regular screenings for hepatitis C, statistics show that many people don’t get tested. There are, however, several reasons for you to talk to your doctor about getting tested for Hepatitis C.”

1 in 10 patients with advanced liver disease develops liver-related event after HCV cure
“The risk for hepatic decompensation and hepatocellular carcinoma remained constant after hepatitis C virus cure among patients with advanced chronic liver disease, underscoring the need for post-HCV risk stratification in the long term.”

Yale Researchers Explore Liver-Brain Connection
“Their study found an association between liver fibrosis and cognitive performance. Some research has suggested that neurotoxic metabolites produced in an injured liver may cross the blood-brain barrier.”

Only 25% of patients with cirrhosis receive transplant referrals at safety-net hospitals
“Nearly 75% of patients with end-stage liver disease in safety-net hospitals were not referred for liver transplant evaluation, mostly due to active alcohol use or insurance issues, according to data published in JAMA Network Open.”